Cargando…

Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms

Radical surgery represents the only curative treatment for pancreatic neuroendocrine neoplasms (PanNEN). The aim of this study was to evaluate the postoperative onset of diabetes mellitus (DM) and/or pancreatic exocrine insufficiency (PEI) in surgically treated PanNEN. Consecutive PanNEN patients, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreasi, Valentina, Partelli, Stefano, Capurso, Gabriele, Muffatti, Francesca, Balzano, Gianpaolo, Crippa, Stefano, Falconi, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832294/ https://www.ncbi.nlm.nih.gov/pubmed/31623399 http://dx.doi.org/10.3390/jcm8101611

Ejemplares similares

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
por: Mapelli, Paola, et al.
Publicado: (2021)

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
por: April-Monn, Simon Leonhard, et al.
Publicado: (2021)

Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology
por: Crippa, Stefano, et al.
Publicado: (2016)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy?
por: Maggi, Giulia, et al.
Publicado: (2018)

Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
por: Massironi, Sara, et al.
Publicado: (2022)

Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies
por: Pecorelli, Nicolò, et al.
Publicado: (2022)

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
por: Cives, Mauro, et al.
Publicado: (2019)

The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
por: Berardi, Rossana, et al.
Publicado: (2020)

Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
por: Pecorelli, Nicolò, et al.
Publicado: (2019)

Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports
por: Rossi, Gemma, et al.
Publicado: (2022)

Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making
por: Marchegiani, Giovanni, et al.
Publicado: (2022)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
por: Gentiluomo, Manuel, et al.
Publicado: (2023)

Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma
por: Vanella, Giuseppe, et al.
Publicado: (2022)

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs
por: Paini, Marina, et al.
Publicado: (2014)

Pancreatic fistula after pancreaticoduodenectomy—does surgical technique matter?
por: Crippa, Stefano, et al.
Publicado: (2020)

Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management
por: Archibugi, Livia, et al.
Publicado: (2022)

A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study †
por: Primavesi, Florian, et al.
Publicado: (2020)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
por: Capurso, Gabriele, et al.
Publicado: (2020)

Long-Term Outcome after Laparoscopic Bowel Resections for Deep Infiltrating Endometriosis: A Single-Center Experience after 900 Cases
por: Ruffo, Giacomo, et al.
Publicado: (2014)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Pancreatic cystic neoplasms in 2018: The final cut
por: Capurso, Gabriele, et al.
Publicado: (2018)

Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
por: Pezzilli, Raffaele, et al.
Publicado: (2020)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy
por: Pecorelli, Nicolò, et al.
Publicado: (2022)

Imaging of Pancreatic Neuroendocrine Neoplasms
por: Chiti, Giuditta, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm?
por: Crippa, Stefano, et al.
Publicado: (2017)

Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study
por: Partelli, Stefano, et al.
Publicado: (2020)

Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases
por: Vanoli, Alessandro, et al.
Publicado: (2022)

EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat?
por: Larghi, Alberto, et al.
Publicado: (2019)

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial
por: Partelli, Stefano, et al.
Publicado: (2022)

New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms
por: Fortunati, Emilia, et al.
Publicado: (2022)

Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms
por: Melita, Giuseppinella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6m9apf2b6rbnl6f023vb2jtlnu